As of October 2024, Mayne Pharma Group has a market cap of $257.41M. This makes Mayne Pharma Group the world's 15467th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $295.77M | -13.50% |
2023 | $341.91M | 53.75% |
2022 | $222.38M | -32.20% |
2021 | $328.01M | -14.49% |
2020 | $383.61M | -20.69% |
2019 | $483.68M | -43.87% |
2018 | $861.73M | 11.51% |
2017 | $772.78M | -48.33% |
2016 | $1.50B | 0.48% |
2015 | $1.49B | 123.38% |
2014 | $666.31M | -12.16% |
2013 | $758.56M | 146.67% |
2012 | $307.53M | -1.10% |
2011 | $310.94M | -44.68% |
2010 | $562.09M | 6.82% |
2009 | $526.21M | 247.37% |
2008 | $151.49M | -55.29% |
2007 | $338.85M | - |